Everads Therapy
Delivery System for Injectable Therapies into the Eye
Startup Seed Health Tech & Life Sciences Est. 2017
🌐 WebsiteLinkedIn
Total Raised
$1M
Seed
Last Round
$1M
1 rounds
Investors
2
2 public
Team
5
1-10 employees
Confidence
100/100
News
6
articles
Patents
1
About
Everads Therapy is an early-stage life sciences company developing retinal treatment delivery technologies. The companys delivery system aims to improve the efficacy and safety of existing and potential drug therapies, with the goal of overcoming significant challenges in current treatment methodologies for retinal and macular diseases. Everads Therapy operates within the RAD Biomed incubator in Tel Aviv, Israel. Its underlying technologies have been licensed from the Sheba Medical Center at Tel Hashomer.
Classification
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsPharma & Medical BiotechnologyDrug Delivery
Target Customer
Healthcare & Life SciencesHealthcareProvidersLife SciencesPharmaceuticals
Business Model
B2B
Tags
cell-therapyophthalmologymedical-devicesclinicshospitalsbiotechnologydoctorsdrug-deliverymedical-technologieseye-diseasesminimally-invasivenanotechnology
Funding & Events
Jan 2017
Seed $1M
EU Horizon 2020, RAD BioMed
News (6)
Jul 30, 2025 · www.prnewswire.com
growth-positive
/PRNewswire/ -- Everads Therapy, a clinical-stage company leveraging its novel suprachoroidal delivery technology to advance the treatment of retinal diseases,...
Product StagePartners
Sep 19, 2024 · www.prnewswire.com
growth-positive
/PRNewswire/ -- Everads Therapy, a clinical stage biotechnology company developing a platform for non-surgical delivery of therapeutics to the back of the eye...
CustomersPartnersExpand
Jun 30, 2021 · www.prnewswire.com
growth-positive
Everads Enters into Collaboration to Evaluate its Suprachoroidal Delivery Technology with a Clinical-Stage Gene Therapy Company
Partners
Aug 18, 2020 · www.prnewswire.com
growth-positive
Global Pharma Company Exercises Rights for Exclusive Use of Everads Drug Delivery Technology in Specific Retinal Targets
Partners
Mar 18, 2020 · en.globes.co.il
growth-positive
Everads Therapy wins retina commercialization option deal
Partners
Mar 12, 2020 · www.prnewswire.com
growth-positive
Everads Therapy Enters Into Option Agreement With Global Pharma Company to License Everads' Suprachoroidal Delivery System for Retinal Disease Therapies
Partners
Details
Product Stage
R&D
Employees
1-10
Exact Count
10
District
Center District
Founded
2017
Registrar
515541324
Crunchbase
everads-therapy
Locations
HaBarzel Street 27, Tel Aviv-Yafo, Israel
Links
Website
www.everads-therapy.com/
LinkedIn
Profile
Admin
Last Update
Jul 2, 2021
Verified by
Vered Waxman
Claimed
Yes
Team (5)
Moshe Weinstein
Executive Chairman & CEO
Dr. Ifat Sher
Co-founder & CSO
Founder
Dr. Ygal Rotenstreich
Co-founder & Medical Director
Founder
David Daily
Co-founder & R&D Director
Founder
Hagay Drori
COO
Internal
Created by
Yotam Maman (yotamm1988@gmail.com)
Created
2019-05-30T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)
Finder · Everads Therapy · 2026